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Hearing loss in hypothyroidism has been reported by many authors but its pathophysiology is 
unclear. 
Aims: to study the audiological evaluation of patients with acquired hypothyroidism. 
Materials and Methods:  two groups were included: a hypothyroidism group (HG, n-30), and 
a control group (CG, n-30). Parameters studied: gender, time of hypothyroidism, comorbidities, 
cochleovestibular symptoms, biochemistry and hormonal exams (TSH, T4), tonal audiometry, TOAEs 
and BERA. 
Results: all participants were women, 70% of the HG had Hashimoto thyroiditis, 60% of the HG 
had had the diagnostic of the hypothyroidism for at least five years. Depression and hypertension 
were frequent in HG. All HG patients had altered TSH values and 50% had diminished T4 values. 
Sensorineural hearing loss was detected in 22 ears from the HG and in seven from the CG. BERA 
was normal in the CG and altered in 10 ears from the HG, showing L-V increase. TOAEs were absent 
in 12 ears from the HG and in four from the CG. 
Conclusions: HG patients had more cochleovestibular symptoms, higher audiometric thresholds, 
increase in L-V in the BERA and absence or reduction in TOAEs amplitudes. Such alterations were 
not associated with THS and free T4 levels. 
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INTRODUCTION
One of the most important dysfunctions of the 
thyroid gland is hypothyroidism (congenital or acquired) 
in which the production or function of thyroid hormones 
is impaired, resulting in generalized reduction of the me-
tabolism of all the systems. Hypothyroidism affects 2% of 
adult women and only 0.2% of men1-3.
Auditory acuity reduction has been associated with 
thyroid gland dysfunction and has been described by nu-
merous authors. In 1974, Ritter stressed that hearing loss 
can be the most common otorhinolaryngological mani-
festation of congenital and acquired hypothyroidism, and 
auditory symptoms may happen alone or in association 
with vertigo and tinnitus4. The real incidence of hearing 
loss in patients with hypothyroidism is still uncertain, 
and it may affect 25% of the patients with acquired hy-
pothyroidism and 35-50% of the patients with congenital 
hypothyroidism5,6. The pathophysiological mechanisms 
of hearing loss in hypothyroidism are not totally unvei-
led. It is known that in this hormonal disorder there is a 
reduction in cell energy production, compromising the 
microcirculation and, consequently, oxygenation and the 
metabolism of the involved organs. Inner ear structures 
are also affected, such as the stria vascularis and the Or-
gan of Corti7. Thyroid hormones control protein synthesis, 
the production of myelin and enzymes and the level of 
lipids in the central nervous system. Moreover, T4 can 
act as a neurotransmitter. Thus, it is believed that under 
hypothyroidism, hearing impairment can originate in the 
cochlea, in the central auditory pathways and/or in the 
retrocochlear region8.
Experimental studies have tried to pinpoint the 
auditory pathway sites affected by hypothyroidism. Sai-
to et al.9, in an experimental study carried out in dogs, 
found a reduction in the number of neuronal cells in the 
cerebral cortex and structural changes in the membranous 
labyrinth and in the petrous portion of the temporal bone. 
Thus, similarly to what happens in diabetes mellitus, the 
hypothyroidism-related hearing impairment seems to in-
volve numerous structures10-12.
Tonal threshold audiometry, Immittance tests and 
electrophysiological methods such as brainstem auditory 
evoked potentials (BAEP) and otoacoustic emissions (EAE) 
have been used to assess patients with hypothyroidism. 
The results from these auditory evaluations, both clinical 
and experimental, are not homogeneous. Studies from 
Ben-Tovim et al.5, in rats, and those from Rubinstein et 
al.13, in swine, both with experimentally induced hypo-
thyroidism, show changes in the amplitude and latency 
of electrophysiological auditory potentials, being reversi-
ble after treatment with thyroid replacement hormones. 
According to Ben-Tovim et al.5, the changes seen in the 
BAEP are directly associated to the serum levels of the 
free T4. Himelfarb et al.14 found a significant drop in the 
audiometric thresholds and BAEP changes in patients with 
thyroid gland dysfunction and highlighted the statistically 
significant relation between hearing loss and low free T4. 
Similarly to that, Anand et al.15 detected reduction in the 
audiometric thresholds and BAEP changes in 16 patients 
(from a total of 20 patients) with hypothyroidism without 
treatment. After the hormonal replacement treatment for 
a period of 3.7 months, the authors reported a marked 
improvement in the audiometric threshold; however, the 
BAEP results maintained altered, there was also a reduc-
tion on the absolute latency amplitudes on waves I, III 
and V and increase in the absolute latency in wave V and 
interpeaks LI-III and L I-V.
Di Lorenzo et al.8, analyzed the auditory evoked 
potentials from patients with hypothyroidism, before and 
after the hormonal replacement therapy and observed 
that 25% of the patients with hypothyroidism with BAEP 
changes, represented by the interauricular difference abo-
ve 0.2 ms, also had increase in wave V absolute latency 
and that of interpeaks LIII-V and LI-V. These changes 
were maintained even after 6 to 12 months of hormonal 
replacement therapy, challenging the reversibility of the 
hearing impairment in these patients.
In subclinical hypothyroidism, results are also con-
troversial. Ozata et al.12 did not observe BAEP changes in 
20 of their patients. On the other hand, Figueiredo et al.16 
assessed 23 patients with subclinical disease and found 
marked differences in the absolute latencies of waves III 
and V, and interpeaks LI-III, LIII-V and LI-V.
The otoacoustic emissions study is a fast and relia-
ble electrophysiological method which has proven useful 
in the investigation of cochlear diseases, as well as in 
assessing hearing in patients with metabolic disorders. 
Khechinaschvili et al.17, assessing the hearing acuity of 50 
patients with hypothyroidism, found that the otoacoustic 
emissions were absent in some patients who had normal 
audiometric thresholds. They also found changes in the 
BAEP of 30% of the patients, suggesting that the auditory 
involvement in patients with hypothyroidism can be mul-
tisectorial.
Considering the above, we notice that the results 
from the audiological evaluation of patients with hypo-
thyroidism are conflicting, making it necessary to broaden 
the studies in this line of research. Thus, the goal of the 
present study was to assess the auditory acuity of patients 
with acquired hypothyroidism, using tonal threshold audio-
metry, brainstem auditory evoked potentials and transient 
otoacoustic emissions.
MATERIALS AND METHODS
This study was approved by the Ethics in Research 
Committee of the University where the study was carried 
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out (protocol # 2023/2006). We setup two study groups: a 
group with hypothyroidism (GH), made up of 30 patients 
with acquired hypothyroidism, confirmed by clinical and 
laboratory exams, and the control group (GC), made up 
of 30 volunteers without thyroid gland disease, belonging 
to the corresponding age range, submitted to the same 
evaluation sequence used in the study group. The follo-
wing exclusion criteria were used: be older than 60 years, 
having been submitted to prior ear surgery, having an 
altered otoscopic exam, work in a noisy environment or 
having an audiometric exam with a result matching that of 
noise-induced hearing loss, having a conductive hearing 
loss or type B or C tympanometric curve, report the use 
of ototoxic medication, report prior history of hereditary 
hearing loss, report hearing loss since childhood or having 
a genetic syndrome.
The clinical parameters investigated were: age, 
hypothyroidism diagnosis time, auditory and/or vestibu-
lar symptoms, biochemical test results (fasting glucose, 
triglycerides, total cholesterol) and hormonal exams (TSH, 
free T4). These values were deemed normal for the pa-
rameters: free T4 and TSH, between 0.8-1.9 ng / dL and 
0.4-4.0 mUI / mL, respectively; fasting glucose between 
70 and 99 mg / dL; total cholesterol below 200 mg / dL; 
triglycerides below 150 mg / dL.
For the auditory evaluations we used the following 
tests: tonal threshold audiometry (A321 Amplaid audio-
meter, Italy), Immittance measures (775  Amplaid device, 
Italy), Transient Otoacoustic Emissions test - TOAE (ILO 
288 Echoport, Otodynamic Ltd., England) and Brainstem 
Auditory Evoked Potential - BAEP (Nihon Koden - Neu-
ropack MEB 7102 k device, Japan).
The audiometric results were classified as to type 
and degree. As far as type is concerned, the losses were 
classified in: conductive (airway thresholds above 25 dB 
and the normal bone conduction threshold, with an air-
bone gap); mixed (air and bone conduction thresholds 
above 25 dB, with air-bone gap) and sensorineural (air 
and bone conduction thresholds above 25 dB, without 
air-bone gap). The patients with conductive or mixed he-
aring loss were taken off the study. Concerning the grade, 
the hearing losses were classified into: mild (thresholds 
between 26 and 40 dB); moderate (thresholds between 
41 and 70 dB); severe (thresholds between 71 and 90 dB) 
and profound (thresholds above 91 dB).
We included in the study those individuals with 
type A tympanometric curve. The criteria used to classify 
TOAE as present or absent were: signal reproducibility 
above 50% and signal amplitude of 3 dB SPL response 
above the noise spectrum in one or more frequencies. 
In the study of the brainstem auditory evoked potentials 
(BAEP) we used the monaural stimulus through filtered 
clicks (between 300 and 4.000 Hz), lasting for 0.1 millise-
conds, frequency of 17 clicks per second and thin polarity. 
The stimulus intensity was of 90 DbSPL, and 2,000 clicks 
were used, within an analysis time of 10ms, keeping the 
electrodes impedance below 5 Kohms. 
Our statistical methods to study the associations 
between the variables and comparison of proportions 
between the groups were the chi-square test, the Fisher’s 
exact test and the Goodman test. In comparing the attri-
butes with normal distribution, we used the t Student test, 
considering 5% as level of significance.
RESULTS
All participants in this study were women and 70% 
of them had hypothyroidism secondary to Hashimoto’s 
thyroiditis. In both groups, there was a predominance of 
the age range between 31 and 50 years over the remaining 
age ranges (p<0.05). Most of the patients with hypothyroi-
dism (60%) had known of the diagnosis for less than five 
years. Subclinical hypothyroidism, in which TSH values 
were altered, keeping normal values of free T4, was seen 
in 50% of the patients with hypothyroidism. Among other 
etiological diagnosis of hypothyroidism, we stress idiopa-
thic, total or partial thyroidectomy.
Most of the participants with hypothyroidism did 
not have comorbidities (53.34%; p<0.05). Depression 
was diagnosed in 26.66% of the remaining patients, and 
hypertension in 13.34
Cochleovestibular symptoms were reported by 
participants from both groups, they were, however, more 
frequent in those patients with hypothyroidism (p<0.05), 
highlighting hearing loss (13.33%), tinnitus (16.67%) and 
vertigo (3.33%). We highlight that 26.67% of these patients 
had the three associated symptoms (Table 1). Most of the 
patients from the control group did not report cochleo-
vestibular symptoms (73.33%).
In the comparative analysis of the biochemical 
exams (fasting glucose, triglycerides and total cholesterol) 
from the participants of both groups, we did not notice 
statistically significant differences (p> 0.05). Diabetes 
mellitus was not seen in any of the participants. Tables 
2, 3 and 4. High TSH levels were seen only among parti-
cipants with hypothyroidism, and 50% of them also had 
reduced levels of free T4.
High audiometric thresholds were recorded from 
22 ears (36.67%) of the patients with hypothyroidism and 
in only seven ears (11.67%) from patients of the control 
group (p<0.05), there was a predominance of mild/mode-
rate sensorineural hearing loss in both groups (Figure 1). 
There was no significant association between the changed 
audiometric thresholds and the serum levels of glucose, 
triglycerides, total cholesterol, TSH and free T4 (p>0.05).
The study of the brainstem auditory evoked poten-
tials (BAEP) was changed in 10 ears from patients with 
hypothyroidism and in none of the participants from the 
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Table 1. List of the cochleovestibular symptoms reported by the participants from both study groups.
Symptoms
Groups
Control N % Hypothyroidism N %
No symptoms 22
73.33a 
A
7
23.33b 
A
Tinnitus 5
16.67a 
B
5
16.67a
A
Hearing loss 1
3.33a 
B
4
13.33a 
A
Hearing loss and tinnitus 2
6.67a 
B
5
16.67a 
A
Hearing loss, tinnitus and vertigo 0
0.00b 
B
8
26.67a 
A
Vertigo 0
0.00a 
B
1
3.33a 
A
TOTAL 30 100.00 30 100.00
χ 2= 19.8; p-0.001
Table 2. Fasting glucose serum levels of the participants from both study groups (mg/dL).
Fasting glucose (mg/dL)
Groups
Control N % Hypothyroidism N %
< 100 27
90.00a 
A
18
60.00b 
A
de 100 a 125 3
 10.00b 
B
12
40.00a 
A
> 125 0
0.00a 
B
0
0.00a 
B
TOTAL 30 100.00 30 100.00
χ 2 = 7.200; p - 0.007
Table 3. Distribution of the patients from both groups in relation to total cholesterol serum levels (mg/dL).
Total cholesterol (mg/dL)
Groups
Control N % Hypothyroidism N %
< 200 19 63.34 12 40.00
de 200 a 239 8 26.66 11 36.66
> 239 3 10.00 7 23.34
TOTAL 30 100.00 30 100.00
χ 2 = 3.654; p - 0.301
Table 4. Distribution of the participants from both groups in relation to their serum levels of triglycerides (mg/dL).
Triglicérides (mg/dL)
Groups
Control N % Hypothyroidism N %
≤150 25 83.34 20 66.67
≥151 5 16.66 10 33.33
TOTAL 30 100.00 30 100.00
χ 2 = 2.222; p - 0.136
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control group (p<0.05). The mean values from the L-V 
absolute latencies proved statistically higher in the group 
with hypothyroidism (p <0.05) (Table 5). The other BAEP 
parameters have similar behavior in both groups.
The transient evoked otoacoustic emissions were 
not present in a higher number of patients with hypo-
thyroidism (20%) when compared to the control group 
(6.67%) (p<0.05). The transient otoacoustic emission 
(TOAE) amplitudes were lower in the group of patients 
with hypothyroidism (p <0.05). In both groups, the values 
from the emissions amplitudes were lower in the higher 
frequencies (Table 6).
DISCUSSION
In the present study, among patients with acquired 
hypothyroidism, Hashimoto’s thyroiditis was the main cau-
se (70%), and such result was already expected because 
it was the main cause of auto-immune hypothyroidism, 
in which the glandular parenchyma is invaded by a lym-
phoplasmocytic infiltrate, producing antibodies against 
the gland18. We stress that 50% of the patients had been 
diagnosed with subclinical hypothyroidism, characterized 
by normal serum concentrations of free T4 and high le-
vels of TSH. In subclinical hypothyroidism, Hashimoto’s 
thyroiditis is also the main cause, corresponding to 50-80% 
of the cases1,2,12,18,19.
In relation to the TSH and free T4 values, we noticed 
that all the patients with hypothyroidism had changed se-
rum levels of TSH. One must consider the fact that all these 
patients were periodically followed up in endocrinology 
wards, they were under hormonal replacement therapy, 
and even then they had changed levels of TSH, with or 
without changes in the levels of free T4.
Table 5. Absolute latencies of waves PI, PIII and PV and of interpeaks LI-III, LIII-V and LI-V (ms) in both study groups.
Mean and standard deviation (DP) of the 
absolute latencies and interpeaks (ms)
Control 
Mean SD
Hypothyroidism
Mean SD
L-I 1.58 ±0.12 1.61 ±0.10
L-III 3.67 ±0.13 3.70 ±0.19
L-V* 5.57 ±0.20 5.65 ±0.20
L I-III 2.08 ±0.13 2.08 ±0.19
L III-V 1.91 ±0.17 1.94 ±0.16
L I-V 3.99 ±0.20 4.02 ±0.21
*p<0.05 (t Student Test).
Table 6. Mean values and standard deviation of the of the transient otoacoustic emissions (TOAE) in each frequency from both groups.
Frequency bands (KHz)
Mean values of the transient otoacoustic emissions (dB)
 Control Hypothyroidism
Mean  SD Mean SD
1KHz 12.08 ±4.17 8.20 ±3.12
1.5KHz 11.33 ±3.87 7.06 ±2.67
2KHz 9.24 ±5.45 5.80 ±2.13
3KHz 7.19 ±4.04 5.00 ±1.76
4KHz 5.83 ±2.57 4.13 ±0.99
p<0.05 (“t” Student test)
Figure 1. Audiometric thresholds in both study groups per ear tested.
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The analysis of cochleovestibular symptoms showed 
that approximately 73% of the volunteers in the control 
group did not have symptoms in this area, nonetheless, 
some of them reported tinnitus alone, similarly to those 
patients with hypothyroidism. Tinnitus is a frequent com-
plaint in the general population, affecting from 35 to 40% 
of adults, and it has multiple causes. Associated symptoms 
of tinnitus, vertigo and hearing loss were reported by 
26.67% of the patients with hypothyroidism, indicating a 
possible joint involvement of the cochlear and vestibular 
systems. Cochleovestibular symptoms associated with 
metabolic disorders are relatively frequent, being chronic 
and permanent20-23.
High audiometric thresholds were recorded in a lar-
ger group of patients with hypothyroidism (22 ears) when 
compared to the patients in the control group, and most 
of them had mild to moderate and bilateral sensorineural 
hearing loss. The pathophysiology of the hearing invol-
vement in metabolic disorders has been studied by many 
researchers. The authors consider that many auditory pa-
thway sites are involved in this process, and endocochlear, 
retrocochlear and central structures may be involved11,17.
In the present study, the most prevalent co-morbidi-
ties were depression (26.66%) and hypertension (13.34%). 
The greatest prevalence of hypertension among individuals 
with hypothyroidism was previously reported by Kotsis et 
al.24 who recorded higher levels of systolic arterial pressure 
in the group of patients with hypothyroidism, when com-
pared to the control group. It is known that hypertension 
is an important predisposing factor to hearing impairment, 
since it affects the cochlear duct structures, especially the 
stria vascularis, which is sensitive to pressure variations.
Other important risk cofactors for hearing loss are 
changes to the biochemical tests. In the present study, 
regarding fasting glycemia, we noticed that 40% of the 
patients with hypothyroidism had moderately high levels 
of fasting glucose (between 100 and 125 mg / dL), no-
netheless, no patient had been diagnosed with diabetes. 
It is very likely that these mildly changed glucose levels 
did not cause hearing impairment. Nonetheless, we stress 
the need for a more in-depth study on the metabolism of 
carbohydrates in order to better interpret the results, such 
as the glucose tolerance test and the insulinemic curve, 
since the literature is full of publications showing the high 
incidence of cochleovestibular symptoms and hearing 
impairment in diabetic patients22,23.
Lipid metabolism disorders may also cause co-
chleovestibular symptoms and compromise inner ear 
structures. In a clinical study, Karlidag et al.25 carried out 
audiometry tests in 274 patients with dyslipidemias and 
in 60 healthy individuals, observing higher audiometric 
thresholds in patients with lipid disorders. By analyzing 
the results from this study, we notice that the triglyceride 
and total cholesterol serum levels were discretely higher 
in both groups, and were probably not associated with 
changed audiologic tests.
As we analyzed the patients with changed audiome-
tric tests, we observed that 75% of them had TSH values 
between 4 and 30 mUI / mL and in only a handful of cases 
the TSH serum levels were very high. Changed audiome-
tric tests were also seen in patients with proper free T4 
levels. Thus, the audiometric thresholds do not seem to 
be associated with the serum levels of these hormones. 
Altered BAEP values were seen in 10 ears from pa-
tients with hypothyroidism, with higher absolute latencies 
of waves I, III and V when compared to the control group; 
however, only the L-V values were statistically different 
(p<0.05). The diagnosis of retrocochlear lesions in hypo-
thyroidism had been already stressed by Anand et al.15 in 
80% of their patients with hormonal disorders, and such 
index was much higher than the one seen in the present 
study. Important BAEP changes were also seen by Figuei-
redo et al.16 in patients with subclinical hypothyroidism, 
stressing the increase in the absolute latency of waves I 
and V, as well as that of interpeaks LI-III, LIII-V and LI-V.
Transient otoacoustic emissions were absent in a 
larger number of people with hypothyroidism. In interpre-
ting the results from otoacoustic emissions, it is important 
to assess not only the presence or absence of the curve, 
but also the response amplitude. They were systematically 
reduced in all the frequencies analyzed in the group of 
patients with hypothyroidism, when compared to those 
in the control group.
CONCLUSIONS
Cochleovestibular symptoms were more frequent in 
patients with hypothyroidism, stressing tinnitus, hearing 
loss and vertigo. Patients with hypothyroidism have a hi-
gher number of changes in audiometric evaluations and in 
electrophysiological tests (BAEO and TOAE). The hearing 
loss was sensorineural, from mild to moderate in intensity 
and bilateral. In the BAEP, the increase in the absolute 
latency of L-V was the most significant change. Patients 
with hypothyroidism had no otoacoustic emission or had 
them with lower amplitudes more frequently than their 
control group counterparts. Audiological changes were not 
associated with TSH or free T4 serum levels. 
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